Skip to main content
Clinical Trials/NCT00517725
NCT00517725CompletedPhase 4

Nebivolol Versus Bisoprolol Versus Carvedilol in Heart Failure: Effects on Exercise Capacity and Hypoxia, Chemoreceptor Response, Pulmonary Function

Centro Cardiologico Monzino1 site in 1 country60 target enrollmentStarted: July 2007Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
exercise capacity

Study Overview

Brief Summary

The investigators test the hypothesis that different beta-blockers had a different influence on chemoreceptor response and lung diffusion capacity.

Both could influence exercise capacity in normoxic as well as hypoxic conditions.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
Single (Investigator)

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Chronic heart failure patients in stable clinical condition

Exclusion Criteria

  • No comorbidity
  • NYHA class IV

Arms & Interventions

Carvedilol

Active Comparator

Intervention: carvedilol (Drug)

Bisoprolol

Active Comparator

Intervention: bisoprolol (Drug)

Nebivolol

Active Comparator

Intervention: Nebivolol (Drug)

Outcomes

Primary Outcomes

exercise capacity

Time Frame: two months

Secondary Outcomes

  • lung diffusion(two months)

Investigators

Sponsor
Centro Cardiologico Monzino
Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials